« Return to News | CROs/Service Providers

CWWeekly May 19th 2008 Issue

Sunday, May 25, 2008 11:59 AM

Top News

i3 Research Acquires Russian CRO and i3 Innovus Creates Late Phase Business

i3 Global is solidifying its presence in Russia through the acquisition of Lege Artis, a Moscow-based contract research organization (CRO). Lege Artis conducts phase I through IV trials in Russia and also has operations in Belarus and Ukraine. The CRO is led by its founder and chief executive officer Tatjana Zwereva, M.D., Ph.D., who will stay on with i3 to run the operation. Alexander Makarkov, M.D., Ph.D., a co-founder, will also be joining i3. Lege Artis will be integrated within i3’s contract research division at i3 Research.

Quintiles Consulting Begins New Path with Eidetics Acquisition

Research Triangle Park, N.C.-based Quintiles took another step in its efforts to expand the CRO’s consulting group through the purchase of biopharma-ceutical consulting firm Eidetics. The firm will be integrated into Quintiles Consulting, a 150-employee company with experts from nearly every segment of the pharmaceutical industry. Eidetics performs health economics, decision-analytics and market research services to help sponsors maximize their products post-launch.

Other breaking news...

  • etrials reports drop in net service revenue...
  • eRT first quarter revenues soar...

Company Profile: An interview with Kazem Kazempour, Ph.D., Amarex

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.